BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Promedior 

5 Great Valley Parkway
Suite 300
Malvern  Pennsylvania  19355  U.S.A.
Phone: 610-560-1435 Fax: 610-560-1436


SEARCH JOBS










 Company News
Promedior Presents Positive Phase 2 Data For PRM-151 In Myelofibrosis At American Society of Hematology Annual Meeting 12/9/2014 9:46:55 AM
Promedior Receives Fast Track Designation For PRM-151 For The Treatment Of Myelofibrosis 11/3/2014 10:46:50 AM
Promedior Announces Presentation Of Retrospective Quantitative Imaging Analysis Of Phase 1b Data In Idiopathic Pulmonary Fibrosis 9/22/2014 9:16:57 AM
Promedior Receives U.S. Orphan Drug Designation For PRM-151 For The Treatment Of Myelofibrosis 9/2/2014 11:28:09 AM
Promedior Receives U.S. Orphan Drug Designation For PRM-151 For Fhe Treatment Of Myelofibrosis 9/2/2014 10:41:41 AM
Promedior Announces Presentation Of Interim Phase 2 Data On PRM-151 In Myelofibrosis At The Upcoming Congress Of European Hematology Association 6/5/2014 7:41:29 AM
Tiny Promedior To Present Positive Phase 2 Myelofibrosis Data Next Week 5/30/2014 6:42:10 AM
Promedior Announces Presentation Of Interim Phase 2 Data On PRM-151 In Myelofibrosis At American Society of Clinical Oncology 5/15/2014 9:14:04 AM
Promedior Attains Patient Enrollment Milestone In Phase 2 Clinical Study Of PRM-151 In Myelofibrosis 1/8/2014 9:04:09 AM
Promedior Initiates Phase 2 Clinical Study of PRM-151 in Myelofibrosis 10/9/2013 9:54:21 AM
12345